C9 H15 N O2 - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

60262-74-0

1,3,5-三(2-羟乙基)-1,3,5-三嗪-2,4,6(1H,3H,5H)三酮与2-氨基乙醇、2,2-二甲基-1,3-丙二醇、2,5-呋喃二酮和

1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(2-hydroxyethyl)-, polymer with 2-aminoethanol, 2,2

无

(C9H15N3O6.C8H8O3.C5H12O2.C4H2O3.C2H7NO)x

详情

供应商

31045-37-1

1,4-苯二羧酸二甲酯与1,2-乙二醇和1,3,5-三(2-羟乙基)-1,3,5-三嗪-2,4,6(1H,3H,5H)-三酮的聚合物

1,4-Benzenedicarboxylic acid, dimethyl ester, polymer with 1,2-ethanediol and 1,3,5-tris(2-hydroxyet;
Dimethyl terephthalate, ethylene glycol, tris(hydroxyethyl)isocyanurate polymer

无

(C10H10O4.C9H15N3O6.C2H6O2)x

详情

供应商

25950-45-2

1,4-苯二羧酸二甲酯与1,3-二氢-1,3-二氧代-5-异苯并呋喃羧酸、1,2-乙二醇、4,4'-亚甲基二(苯胺)和1,3,5-三(

1,4-Benzenedicarboxylic acid, dimethyl ester, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarb;
Ethylene glycol, trimellitic anhydride, methylenedianiline, dimethylterephthalate, tris(2-hydroxyethyl) isocyanurate polymer

无

(C13H14N2.C10H10O4.C9H15N3O6.C9H4O5.C2H6O2)x

详情

供应商

24938-17-8

1,4-苯二羧酸与1,3-二氢-1,3-二氧-5-异苯呋喃羧酸、1,2-乙二醇、4,4-甲基苯(苯甲基)和1,3,5-三(2-羟乙基)-1

1,4-Benzenedicarboxylic acid, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid, 1,2

无

(C13H14N2.C9H15N3O6.C9H4O5.C8H6O4.C2H6O2)X

详情

供应商

25231-54-3

N-(1,1-二甲基-3-氧代丁基)-2-丙烯酰胺与2-丙烯酰胺的聚合物

2-Propenamide, N-(1,1-dimethyl-3-oxobutyl)-, polymer with 2-propenamide 2-Propenamide,N-(1,1-dimethy

无

(C9H15NO2.C3H5NO)x

详情

供应商

68083-93-2

N,N,N-三甲基-2-[(2-甲基-1-氧代-2-丙烯基)氧]-乙铵甲基磺酸化物、-2-甲基-2-丙烯酸2-(二甲胺基)乙酯的聚合

Ethanaminium, N,N,N-trimethyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, methyl sulfate, polymer with 2-(d

无

(C9H18NO2.C8H15NO2.C2H4O2.CH3O4S)x

详情

供应商

118691-42-2

Atrial natriureticpeptide-21 (Rana catesbeiana reduced) (9CI);
Atriopeptin-21(rat reduced), 1-de-L-serine-2-de-L-serine-6-L-serine-17-L-methionine-20-glycine-21-L-arginine-21a-L-arginine-21b-L-phenylalanine-;
288: PN: WO0069900 SEQID: 470 unclaimed sequence;
388: PN: US20090175821 SEQID:470 claimed protein;
L-Phenylalanine, L-cysteinyl-L-phenylalanylglycyl-L-seryl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-arginyl-L-arginyl-

Alamethicin I;
Alamethicin(synthetic Trichoderma viride);
Alamethicin F 30;
Alamethicin RF 30;
Alamethicin g;
Antibiotic U 22324;
L-Glutamamide,N-acetyl-2-methylalanyl-L-prolyl-2-methylalanyl-L-alanyl-2-methylalanyl-L-alanyl-L-glutaminyl-2-methylalanyl-L-valyl-2-methylalanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-a-glutamyl-N1-[1-(hydroxymethyl)-2-phenylethyl]-,(S)-

C-Type natriureticpeptide-22 (Triakis scyllium reduced) (9CI);
C-Typenatriuretic factor-22 (pig reduced),2-L-proline-4-L-arginine-9-L-valine-16-L-alanine-;
C-Type natriuretic factor-22(Triakis scyllium reduced);
L-Cysteine,glycyl-L-prolyl-L-seryl-L-arginylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-valyl-L-lysyl-L-leucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-methionyl-L-serylglycyl-L-leucylglycyl-

C-Type natriureticpeptide-22 (swine reduced) (9CI);
C-Typenatriuretic factor-22 (swine reduced);
13: PN: US20090286256 SEQID: 13unclaimed protein;
13: PN: US20090286329 SEQID: 13 unclaimed protein;
13: PN:WO2009143098 SEQID: 13 unclaimed protein;
18: PN: WO0071576 SEQID: 17 unclaimedsequence;
1: PN: WO2005094889 SEQID: 1 claimed protein;
1: PN: WO2009067639SEQID: 1 claimed protein;
21: PN: WO2007047504 SEQID: 14 unclaimed sequence;
29: PN: US20070049521 SEQID: 28 unclaimed sequence;
2: PN: US20030069186 SEQID:8 claimed protein;
335: PN: WO0069900 SEQID: 517 unclaimed sequence;
3: PN:DE19942230 SEQID: 8 claimed protein;
3: PN: US20030069186 SEQID: 9 unclaimedsequence;
3: PN: WO0044399 PAGE: 2 claimed sequence;
429: PN: US20090175821SEQID: 517 claimed protein;
444: PN: US20080312157 SEQID: 487 unclaimedsequence;
4: PN: WO02074234 FIGURE: 3C claimed protein;
5: PN: WO2009142307SEQID: 101 claimed protein;
6: PN: US20010027181 SEQID: 9 unclaimed sequence;
6: PN: WO2008031045 SEQID: 6 claimed sequence;
75: PN: US20060293232 TABLE: 1unclaimed se

Trichosporin B Ia (9CI);
Alamethicin I,2-L-alanine-3-L-serine-6-(2-methylalanine)-9-L-leucine-18-L-glutamine-;
L-Glutamamide,N-acetyl-2-methylalanyl-L-alanyl-L-seryl-L-alanyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-2-methylalanyl-L-leucyl-2-methylalanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-N1-[1-(hydroxymethyl)-2-phenylethyl]-,(S)-

Trichosporin B VIa(9CI);
AlamethicinI, 2-L-alanine-6-(2-methylalanine)-9-L-isoleucine-18-L-glutamine-;
L-Glutamamide,N-acetyl-2-methylalanyl-L-alanyl-2-methylalanyl-L-alanyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-2-methylalanyl-L-isoleucyl-2-methylalanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-N1-[1-(hydroxymethyl)-2-phenylethyl]-,(S)-

Trichosporin B IVc(9CI);
AlamethicinI, 2-L-alanine-6-(2-methylalanine)-18-L-glutamine-;
L-Glutamamide,N-acetyl-2-methylalanyl-L-alanyl-2-methylalanyl-L-alanyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-2-methylalanyl-L-valyl-2-methylalanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-N1-[1-(hydroxymethyl)-2-phenylethyl]-,(S)-;
Longibrachin LGA III;
Metanicin C;
Trichokonin VIII

Trichosporin B V (9CI);
AlamethicinI, 2-L-alanine-3-L-alanine-6-(2-methylalanine)-9-L-isoleucine-18-L-glutamine-;
L-Glutamamide,N-acetyl-2-methylalanyl-L-alanyl-L-alanyl-L-alanyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-2-methylalanyl-L-isoleucyl-2-methylalanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-N1-[1-(hydroxymethyl)-2-phenylethyl]-,(S)-

Trichosporin B IIIa(9CI);
AlamethicinI, 2-L-alanine-3-L-alanine-6-(2-methylalanine)-9-L-leucine-18-L-glutamine-;
L-Glutamamide,N-acetyl-2-methylalanyl-L-alanyl-L-alanyl-L-alanyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-2-methylalanyl-L-leucyl-2-methylalanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-glutaminyl-N1-[1-(hydroxymethyl)-2-phenylethyl]-,(S)-

(ALA92)-PEPTIDE 6

(ALA92)-P16 (84-103);
OSTEOCALCIN [ALA92]-P16 FRAGMENT 84-103;
OSTEOCALCIN [ALA92]-PEPTIDE 6;
H-ASP-ALA-ALA-ARG-GLU-GLY-PHE-LEU-ALA-THR-LEU-VAL-VAL-LEU-HIS-ARG-ALA-GLY-ALA-ARG-OH;
ASP-ALA-ALA-ARG-GLU-GLY-PHE-LEU-ALA-THR-LEU-VAL-VAL-LEU-HIS-ARG-ALA-GLY-ALA-ARG;
(ALA92)-P16 (84-103);
(ALA92)-PEPTIDE 6;
[ala92]-p16 fragment 84-103

NATRIURETIC PEPTIDE, C-TYPE;
CNP

C-TYPE NATRIURETIC PEPTIDE (32-53) (HUMAN, PORCINE, RAT);
NATRIURETIC PEPTIDE, C-TYPE, HUMAN AND PORCINE;
GLY-LEU-SER-LYS-GLY-CYS-PHE-GLY-LEU-LYS-LEU-ASP-ARG-ILE-GLY-SER-MET-SER-GLY-LEU-GLY-CYS;
GLSKGCFGLKLDRIGSMSGLGC;
GLSKGCFGLKLDRIGSMSGLGC (DISULFIDE BRIDGE: 6-22);
H-GLY-LEU-SER-LYS-GLY-CYS-PHE-GLY-LEU-LYS-LEU-ASP-ARG-ILE-GLY-SER-MET-SER-GLY-LEU-GLY-CYS-OH;
H-GLY-LEU-SER-LYS-GLY-CYS-PHE-GLY-LEU-LYS-LEU-ASP-ARG-ILE-GLY-SER-MET-SER-GLY-LEU-GLY-CYS-OH (DISULFIDE BRIDGE: 6-22);
CNP;
CNP-22, HUMAN

神经储钙蛋白基质

ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU;
ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU;
DLDVPIPGRFDRRVSVAAE;
CALCINEURIN (PP2B) SUBSTRATE [DLDVPIPGRFDRRVSSVAAE], NON-PHOSPHORYLATED;
CALCINEURIN SUBSTRATE;
H-ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU-OH;
[ALA-97]-RII (81-99);
Calcineurin (PP2B) Substrate [DLDVPIPGRFDRRVSVAAE], Non-Phosphorylated

CYS-PHE-GLY-SER-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-MET-GLY-CYS-GLY-ARG-ARG-PHE (DISULFIDE BRIDG

ATRIAL NATRIURETIC PEPTIDE (4-24), FROG;
H-CYS-PHE-GLY-SER-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-MET-GLY-CYS-GLY-ARG-ARG-PHE-OH (DISULFIDE BRIDGE: 1-17);
FANP-21;
CFGSRIDRIGAQSGMGCGRRF (DISULFIDE BRIDGE: 1-17);
ATRIAL NATRIURETIC PEPTIDE (4-24), FROG;
ATRIAL NATRIURETIC PEPTIDE FROG: FRAGMENT 4-24;
anf 4-24;
atrial natriuretic peptide fragment 4-24 frog;
ANF 4-24, fANP-21

CASEIN KINASE II;
RHCKII;
CASEIN KINASE II, HUMAN, RECOMBINANT;
CASEIN KINASE 2;
CASEIN KINASE II;
EC 2.7.1.37;
CK 2;
CK II;
casein kinase ii from rat liver

无

C90H153N27O26

详情

供应商

化工产品